NORTH VANCOUVER, BC, Canada, October 2, 2008 - Investigators at the Princess Margaret Hospital, University of Colorado Cancer Center & BC Cancer Agency will present "Phase I study of the ribosome inactivating protein prodrug TST10088 (TST88) in patients with advanced...